Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pharming (PHAR) Non Operating Income (2021 - 2025)

Historic Non Operating Income for Pharming (PHAR) over the last 4 years, with Q3 2025 value amounting to $1.7 million.

  • Pharming's Non Operating Income rose 17973.98% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.8 million, marking a year-over-year decrease of 13156.77%. This contributed to the annual value of $1.9 million for FY2024, which is 12981.38% up from last year.
  • As of Q3 2025, Pharming's Non Operating Income stood at $1.7 million, which was up 17973.98% from -$8.5 million recorded in Q2 2025.
  • In the past 5 years, Pharming's Non Operating Income ranged from a high of $3.6 million in Q2 2024 and a low of -$8.5 million during Q2 2025
  • Moreover, its 4-year median value for Non Operating Income was $6591.0 (2021), whereas its average is -$1.6 million.
  • Its Non Operating Income has fluctuated over the past 5 years, first skyrocketed by 18042.65% in 2024, then crashed by 211524.66% in 2025.
  • Quarter analysis of 4 years shows Pharming's Non Operating Income stood at $6591.0 in 2021, then crashed by 96231.09% to -$6.3 million in 2023, then skyrocketed by 107.23% to $458000.0 in 2024, then soared by 274.67% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, -$8.5 million for Q2 2025, and -$4.5 million during Q1 2025.